Related Experiment Video
Updated: Sep 9, 2025

10:16
In Vitro Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease
Published on: December 20, 2017
8.2K
Medical Expert Knowledge Meets AI to Enhance Symptom Checker Performance for Rare Disease Identification in Fabry
Anne Pankow1,2, Nico Meißner-Bendzko3, Jessica Kaufeld4
1Department of Rheumatology and Clinical Immunology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
JMIR AI
|August 28, 2025
Summary
Integrating expert insights into AI symptom checkers improves rare disease diagnosis. This enhancement led to better accuracy and user satisfaction for identifying conditions like Fabry disease.
Area of Science:
- Medical informatics
- Artificial intelligence in healthcare
- Rare disease diagnostics
Background:
- Rare diseases present diagnostic challenges, often leading to delays and increased healthcare costs.
- Artificial intelligence (AI)-powered symptom checkers (SCs) show promise for early rare disease detection.
- Current SCs rely on literature data, which may be incomplete for rare diseases, impacting accuracy.
Purpose of the Study:
- To enhance AI-powered SCs by incorporating expert interview vignettes.
- To evaluate if this novel approach improves diagnostic accuracy for rare diseases.
- To assess user satisfaction with the enhanced SC, focusing on Fabry disease.
Main Methods:
- A mixed-methods pilot study at Hannover Medical School, Germany.
- Expert interviews generated clinical vignettes to enrich the AI SC's Fabry disease model.
- Patients with Fabry disease evaluated both original and optimized SC versions for diagnostic accuracy and satisfaction.
Main Results:
- Expert vignettes improved AI SC performance in identifying Fabry disease.
- The optimized SC identified Fabry disease as the top suggestion in 33% of cases, versus 17% for the original.
- User satisfaction was higher with the optimized SC, citing better symptom coverage and completeness.
Conclusions:
- Integrating expert-derived vignettes enhances AI SCs for rare disease diagnosis.
- The optimized SC demonstrated improved diagnostic accuracy and user satisfaction for Fabry disease.
- Future research should include atypical presentations and larger validation studies.

